PALB2 and neoplasm: For the 10 non–HGSC-like OCS (wild-type p53), seven had tumor and/or germline BRCA1/2 testing with no pathogenic mutations involving BRCA1/2 or other HRD genes such as PALB2, RAD51D/C, or BRIP1 identified.